GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tilray Brands Inc (NAS:TLRY) » Definitions » Pretax Margin %

TLRY (Tilray Brands) Pretax Margin % : -16.88% (As of Aug. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Tilray Brands Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Tilray Brands's Pre-Tax Income for the three months ended in Aug. 2024 was $-33.8 Mil. Tilray Brands's Revenue for the three months ended in Aug. 2024 was $200.0 Mil. Therefore, Tilray Brands's pretax margin for the quarter that ended in Aug. 2024 was -16.88%.

The historical rank and industry rank for Tilray Brands's Pretax Margin % or its related term are showing as below:

TLRY' s Pretax Margin % Range Over the Past 10 Years
Min: -1185.81   Med: -29.25   Max: 97.13
Current: -28.84


TLRY's Pretax Margin % is ranked worse than
79.9% of 995 companies
in the Drug Manufacturers industry
Industry Median: 5.23 vs TLRY: -28.84

Tilray Brands Pretax Margin % Historical Data

The historical data trend for Tilray Brands's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tilray Brands Pretax Margin % Chart

Tilray Brands Annual Data
Trend May15 May16 May17 May18 May19 May20 May21 May22 May23 May24
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -26.94 -67.24 -70.13 -231.24 -31.56

Tilray Brands Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -27.46 -25.58 -57.27 -18.71 -16.88

Competitive Comparison of Tilray Brands's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Tilray Brands's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tilray Brands's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tilray Brands's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Tilray Brands's Pretax Margin % falls into.



Tilray Brands Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Tilray Brands's Pretax Margin for the fiscal year that ended in May. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: May. 2024 )/Revenue (A: May. 2024 )
=-249.02/788.942
=-31.56 %

Tilray Brands's Pretax Margin for the quarter that ended in Aug. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Aug. 2024 )/Revenue (Q: Aug. 2024 )
=-33.766/200.044
=-16.88 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tilray Brands  (NAS:TLRY) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Tilray Brands Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Tilray Brands's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tilray Brands Business Description

Traded in Other Exchanges
Address
265 Talbot Street West, Leamington, ON, CAN, N8H 5L4
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.
Executives
Carl A Merton officer: Chief Financial Officer C/O TILRAY, INC., 745 FIFTH AVENUE, SUITE 1602, NEW YORK NY 10151
Denise M Faltischek officer: Chief Strategy Officer C/O THE HAIN CELESTIAL GROUP, INC., 1111 MARCUS AVENUE, LAKE SUCCESS NY 11042
Mitchell Gendel officer: Global General Counsel EMERALD HOLDING, INC., 100 BROADWAY, 14TH FLOOR, NEW YORK NY 10005
Irwin D Simon director, officer: President & CEO C/O THE HAIN CELESTIAL GROUP INC., 1111 MARCUS AVENUE, LAKE SUCCESS NY 11042
Brendan Kennedy director 1920 EASTLAKE AVENUE E., SEATTLE WA 98105
James R. Meiers officer: Head of Canada C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
David G. Hopkinson director C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
Thomas P. Looney director C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
Johann Michael Herhalt director C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
Jodi L. Butts director C/O TILRAY, INC., 655 MADISON AVENUE, 19TH FLOOR, NEW YORK NY 10065
David F Clanachan director TIM HORTONS INC., 874 SINCLAIR ROAD, OAKVILLE A6 L6K 2Y1
Renah Persofsky director 55 PRINCE ARTHUR AVENUE, #604, TORONTO A6 M5R 1B3
Jon Edward Levin officer: Chief Operating Officer 2701 EASTLAKE AVE E, 3RD FLOOR, SEATTLE WA 98102
Michael C. Kruteck officer: Chief Financial Officer 2701 EASTLAKE AVE E, 3RD FLOOR, SEATTLE WA 98102
Rebekah Dopp director 444 LENOX AVENUE, SOUTH ORANGE NJ 07079